SCHEMBL6164529

SCHEMBL6164529

O=C1CCc2c1c(Cc1cccs1)nn2CCO

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.42
PARP1 P09874 1/20 0.39
HPGD P15428 1/20 0.32
CASP3 P42574 1/20 0.32
CASP7 P55210 1/20 0.32
HSD17B10 Q99714 4/20 0.32
MAPT P10636 2/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
KMT2A Q03164 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA2B P29275 1/20 0.32
ADORA1 P30542 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
POLB P06746 2/20 0.32
USP2 O75604 1/20 0.32
TSHR P16473 1/20 0.32
HTR6 P50406 1/20 0.31
LMNA P02545 1/20 0.31
FPR1 P21462 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6162649 0.85 PARP1 (0.37) PARP1CASP7HSD17B10MAPTMEN1
SCHEMBL6167339 0.79 HTT (0.45) HTTPARP1HPGDCASP7HSD17B10
SCHEMBL6164169 0.69 HTT (0.48) HTTHSD17B10MEN1ALDH1A1KMT2A
SCHEMBL6167721 0.67 HTT (0.48) HTT
SCHEMBL6166844 0.66 PARP1 (0.35) PARP1HSD17B10MAPTMEN1ALDH1A1
SCHEMBL6166822 0.66 HTT (0.44) HTTMAPTMEN1ALDH1A1KMT2A
SCHEMBL6164980 0.66 HTT (0.44) HTT
SCHEMBL6166773 0.66 HTT (0.52) HTT
SCHEMBL6165037 0.65 MAOB (0.42) CASP7HSD17B10MAPTMEN1ALDH1A1
SCHEMBL6162358 0.65 HTT (0.46) HTTHPGDMAPTMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed